Tokyo, Japan

Yorikata Sano

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Astellas Pharma Gmbh. Active years: 2006-2025.

USPTO Granted Patents = 4 

% Patents Active = 25.0

Average Co-Inventor Count = 4.8

ph-index = 1


Location History:

  • Tsukuba, JP (2006)
  • Ibaraki, JP (2007)
  • Tokyo, JP (2009)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yorikata Sano: Innovator in Pharmaceutical Research

Introduction

Yorikata Sano is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative therapies and diagnostic tools. With a total of 4 patents to his name, Sano's work is recognized for its potential impact on cancer treatment and cognitive enhancement.

Latest Patents

One of Sano's latest patents is focused on a complex that includes an anti-human MUC1 antibody Fab fragment, peptide linker, and/or ligand. This invention provides a conjugate that comprises the anti-human MUC1 antibody Fab fragment and a peptide linker or ligand. It also includes a composition for diagnosis and/or a pharmaceutical composition that utilizes this conjugate. The method described in this patent aims to diagnose and treat cancer effectively.

Another notable patent involves a method for screening agents that improve memory and learning ability. This patent outlines a screening tool and method for identifying substances that can serve as agents for enhancing memory, learning ability, and potentially acting as antidementia agents. The screening tool is composed of a calcium-permeable nonselective cation channel or a cell expressing this channel, which is crucial for the development of novel therapeutic agents.

Career Highlights

Yorikata Sano is currently associated with Astellas Pharma GmbH, where he continues to advance his research in pharmaceuticals. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges.

Collaborations

Sano collaborates with esteemed colleagues, including Kohei Inamura and Shinobu Mochizuki. Their combined expertise contributes to the success of their research initiatives and the development of groundbreaking therapies.

Conclusion

Yorikata Sano's contributions to pharmaceutical research exemplify the spirit of innovation in the field. His patents reflect a dedication to improving health outcomes through advanced therapeutic solutions. His work continues to inspire future advancements in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…